Literature DB >> 29744526

[Drugs for intravenous induction of anesthesia: barbiturates].

C Dumps1, E Halbeck2, D Bolkenius2.   

Abstract

The discovery of barbituric acid and research on its derivatives have long been of importance in advancements in modern anesthesia. Decades of clinical use of barbiturates worldwide and their abuse has led to an enormous amount of knowledge. Thiopental and methohexital are ultra-short acting derivatives of barbiturates. Their clinical application has been accompanied by an enormous increase in the knowledge of the pharmacology of cerebrally active drugs, in particular gamma-aminobutyric acid (GABAA) receptor and GABA-induced effects on nerve cell membranes. Despite the development of newer substances, thiopental still has a firm place in clinical applications. Currently it is mainly used in obstetrics for induction of cesarean sections under general anesthesia. A disadvantage, when properly used to induce anesthesia, is usually only the prolonged elimination kinetics of barbiturates. It is beneficial that barbiturates do not require side effect provoking solubilizers.

Entities:  

Keywords:  Cesarean section; Methohexital; Pharmacodynamics; Pharmacokinetics; Thiopental

Mesh:

Substances:

Year:  2018        PMID: 29744526     DOI: 10.1007/s00101-018-0440-7

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  53 in total

Review 1.  Which anesthetic agents for ambulatory electro-convulsive therapy?

Authors:  Ross D MacPherson
Journal:  Curr Opin Anaesthesiol       Date:  2015-12       Impact factor: 2.706

2.  Acute tolerance to thiopental.

Authors:  B B BRODIE; L C MARK; P A LIEF; E BERNSTEIN; E M PAPPER
Journal:  J Pharmacol Exp Ther       Date:  1951-08       Impact factor: 4.030

3.  Gas chromatographic assay for free and total plasma levels of thiopental.

Authors:  K E Becker
Journal:  Anesthesiology       Date:  1976-12       Impact factor: 7.892

Review 4.  [Anesthesiological management of Caesarean sections : nationwide survey in Germany].

Authors:  H E Marcus; A Behrend; R Schier; O Dagtekin; P Teschendorf; B W Böttiger; F Spöhr
Journal:  Anaesthesist       Date:  2011-08-12       Impact factor: 1.041

5.  Haemodynamic and catecholamine changes after induction of anaesthesia with either thiopentone or propofol with suxamethonium.

Authors:  M J Brossy; M F James; P K Janicki
Journal:  Br J Anaesth       Date:  1994-05       Impact factor: 9.166

Review 6.  Hepatotoxicity: a scheme for generating chemical categories for read-across, structural alerts and insights into mechanism(s) of action.

Authors:  M Hewitt; S J Enoch; J C Madden; K R Przybylak; M T D Cronin
Journal:  Crit Rev Toxicol       Date:  2013-08       Impact factor: 5.635

7.  Screening of certain anaesthetic agents for their ability to elicit acute porphyric phases in susceptible patients.

Authors:  G H Blekkenhorst; G G Harrison; E S Cook; L Eales
Journal:  Br J Anaesth       Date:  1980-08       Impact factor: 9.166

8.  Flumazenil reduces the duration of thiopentone but not of propofol anaesthesia in humans.

Authors:  A Fassoulaki; C Sarantopoulos; K Papilas
Journal:  Can J Anaesth       Date:  1993-01       Impact factor: 5.063

Review 9.  Pharmacological perioperative brain neuroprotection: a qualitative review of randomized clinical trials.

Authors:  F Bilotta; A W Gelb; E Stazi; L Titi; F P Paoloni; G Rosa
Journal:  Br J Anaesth       Date:  2013-04-05       Impact factor: 9.166

Review 10.  Comparison of Intravenous Anesthetic Agents for the Treatment of Refractory Status Epilepticus.

Authors:  Michael E Reznik; Karen Berger; Jan Claassen
Journal:  J Clin Med       Date:  2016-05-19       Impact factor: 4.241

View more
  2 in total

1.  [67-year-old male in resuscitation room for treatment after traffic accident : Preparation for the medical specialist examination: Part 7].

Authors:  C Dumps; D Bolkenius
Journal:  Anaesthesist       Date:  2019-04       Impact factor: 1.041

Review 2.  GABAA receptors as targets for anaesthetics and analgesics and promising candidates to help treat coronavirus infections: A mini-review.

Authors:  Yujia Luo; Thomas Balle
Journal:  Basic Clin Pharmacol Toxicol       Date:  2022-09-27       Impact factor: 3.688

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.